Accelerated Natriuresis Induced by Synthetic Atrial Natriuretic Polypeptide in Spontaneously Hypertensive Rats

Masahiro Kihara, Kazuhisa Nakayama, Kazuwa Nakao, Akira Sugawara, Narito Morii, Makoto Sakamoto, Mitsuaki Suda, Masanori Shimokura, Yoshiaki Kiso, Hiroo Imura,

Clinical and Experimental Hypertension Part A Theory and Practice · 1985 · 17 citations · 16 references

Concepts

Abstract

Effects of synthetic alpha human atrial natriuretic polypeptide (alpha-hANP) on diuresis, natriuresis and mean arterial blood pressure (MAP) were compared between 4-5 month-old male spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY) under ether anesthesia. In both groups, the peptide injected (0.5 micrograms/100g body weight, i.v.) caused potent (about ten fold), rapid and short-acting (for 15 min) increases in sodium (Na+) and chloride excretions and also an increase in urine flow and potassium excretion with lesser magnitude. Although ratios of the maximum response to basal value were much the same, net increases in urine flow and Na+ output were significantly greater in SHR than in WKY. As to the effect on MAP, a rapid (within 2 min) fall observed in the two groups. These results suggest that the atrial natriuretic peptide may be involved in the altered regulatory mechanism of fluid and electrolyte balance in SHR models with genetic hypertension.

References

16